Hornsby P J, Aldern K A, Harris S E
Biochem Pharmacol. 1986 Oct 1;35(19):3209-19. doi: 10.1016/0006-2952(86)90415-6.
In cultured bovine adrenocortical cells, loss of 17 alpha-hydroxylase activity was observed after incubation with 3-methylcholanthrene (3-MC). The suppression of 17 alpha-hydroxylase by 3-MC was rapid (50% loss of activity in 10 hr at 1 microM 3-MC), did not exhibit a lag period, and was not affected by cycloheximide. Direct effects of 3-MC on 17 alpha-hydroxylase were observed only at high concentrations, but the concentration for 50% loss of activity was 0.3 microM when 3-MC was added for 24 hr prior to assay of 17 alpha-hydroxylase. High concentrations (to 40 microM) of substrate (progesterone), did not affect the loss of activity due to 3-MC. Loss of 17 alpha-hydroxylase activity was specific; 11 beta-hydroxylase was unaffected and cell growth was unaltered. However, 22-amino-23,24-bisnorchol-5-en-3 beta-ol, an inhibitor of 17 alpha-hydroxylase, partially prevented the loss of 17 alpha-hydroxylase at 1-30 nM. 3-MC is thought to induce cytochrome P-450s via a receptor with high affinity for 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). TCDD was without effect on 17 alpha-hydroxylase over the range of 10 nM to 10 microM. Benz[a]anthracene, 7,12-dimethylbenz[a]anthracene, benzo[a]pyrene, chrysene, and methylphenanthrenes suppressed 17 alpha-hydroxylase at high concentrations (10-50 microM for 50% loss of activity). Some steroids that lack a substituent at position 17 also caused loss of 17 alpha-hydroxylase. Like 17 alpha-hydroxylase, bovine adreno-cortical cell AHH was found to be suppressed by exposure to 3-MC. Compounds that caused loss of 17 alpha-hydroxylase caused loss of AHH, with a similar order of potency and at similar concentrations. Suppression of AHH by 3-MC did not require protein synthesis and was prevented by an inhibitor of enzymatic activity, alpha-naphthoflavone. This implies a degree of similarity of the cytochrome P-450s for 17 alpha-hydroxylase and adrenal AHH, but the activities were shown to be likely due to different enzymes. The suppression of 17 alpha-hydroxylase and AHH by 3-MC appears not to occur by a receptor-mediated mechanism but to be similar to the suppression of 11 beta-hydroxylase and 21-hydroxylase by steroid pseudosubstrates previously observed.
在培养的牛肾上腺皮质细胞中,用3-甲基胆蒽(3-MC)孵育后观察到17α-羟化酶活性丧失。3-MC对17α-羟化酶的抑制作用迅速(在1μM 3-MC存在下10小时内活性丧失50%),无延迟期,且不受环己酰亚胺影响。仅在高浓度时观察到3-MC对17α-羟化酶的直接作用,但在测定17α-羟化酶之前加入3-MC 24小时时,活性丧失50%的浓度为0.3μM。高浓度(至40μM)的底物(孕酮)不影响因3-MC导致的活性丧失。17α-羟化酶活性丧失具有特异性;11β-羟化酶未受影响,细胞生长也未改变。然而,17α-羟化酶抑制剂22-氨基-23,24-双降胆甾-5-烯-3β-醇在1-30 nM时可部分阻止17α-羟化酶活性丧失。3-MC被认为通过对2,3,7,8-四氯二苯并对二恶英(TCDD)具有高亲和力的受体诱导细胞色素P-450。在10 nM至10μM范围内,TCDD对17α-羟化酶无影响。苯并[a]蒽、7,12-二甲基苯并[a]蒽、苯并[a]芘、 Chrysene和甲基菲在高浓度(活性丧失50%时为10-50μM)下抑制17α-羟化酶。一些在17位缺乏取代基的类固醇也导致17α-羟化酶活性丧失。与17α-羟化酶一样,发现牛肾上腺皮质细胞芳烃羟化酶(AHH)暴露于3-MC后受到抑制。导致17α-羟化酶活性丧失的化合物也导致AHH活性丧失,效力顺序和浓度相似。3-MC对AHH的抑制不需要蛋白质合成,并被酶活性抑制剂α-萘黄酮所阻止。这意味着17α-羟化酶和肾上腺AHH的细胞色素P-450有一定程度的相似性,但已表明这些活性可能归因于不同的酶。3-MC对17α-羟化酶和AHH的抑制似乎不是通过受体介导的机制发生的,而是类似于先前观察到的类固醇假底物对11β-羟化酶和21-羟化酶的抑制。